Mukul Mehta Set To Succeed Harry Kirsch As CFO Of Novartis

Mukul Mehta has been appointed as the incoming Chief Financial Officer (CFO) and member of the Executive Committee of Novartis (ECN), effective March 16, 2026.

Mehta will succeed Harry Kirsch, who will retire after serving as CFO since 2013 and spending 22 years with the company. Kirsch will continue in his role until March 15, 2026.

Mehta has over two decades of experience at Novartis and currently serves as head of BPA, digital finance, and tax. His previous roles include CFO International, CFO for Pharmaceuticals Europe, and country CFO in France, Poland, and Norway. He holds a master’s degree in business administration (MBA) from INSEAD.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: